Blueberries Medical (Blueberries Medical) Debt-to-Equity : 3.28 (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Blueberries Medical Debt-to-Equity?

Blueberries Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $1.07 Mil. Blueberries Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.11 Mil. Blueberries Medical's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $0.36 Mil. Blueberries Medical's debt to equity for the quarter that ended in Sep. 2023 was 3.28.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Blueberries Medical's Debt-to-Equity or its related term are showing as below:

BBRRF' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.01 Med: 0.4 Max: 47.54
Current: 3.28

During the past 10 years, the highest Debt-to-Equity Ratio of Blueberries Medical was 47.54. The lowest was -0.01. And the median was 0.40.

BBRRF's Debt-to-Equity is ranked worse than
96.72% of 853 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs BBRRF: 3.28

Blueberries Medical Debt-to-Equity Historical Data

The historical data trend for Blueberries Medical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blueberries Medical Debt-to-Equity Chart

Blueberries Medical Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

Get a 7-Day Free Trial

0.10

0.38

1.00

0.91

Blueberries Medical Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Debt-to-Equity	Get a 7-Day Free Trial															47.48	0.91	1.33	2.15	3.28

Competitive Comparison of Blueberries Medical's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Blueberries Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Blueberries Medical's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blueberries Medical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Blueberries Medical's Debt-to-Equity falls into.

Blueberries Medical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Blueberries Medical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.881	+	0.102)	/	1.081
	=	0.91

Blueberries Medical's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.072	+	0.112)	/	0.361
	=	3.28

Blueberries Medical (OTCPK:BBRRF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Blueberries Medical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Blueberries Medical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Blueberries Medical (Blueberries Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blueberries Medical Corp (OTCPK:BBRRF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

1OA:Germany BBM:Canada

Address

8500 West Georgia Street, Suite 2200, Vancouve, BC, CAN, V6C 3E8

Website

https://www.blueberriesmed.com

Blueberries Medical Corp is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. It generates all of its revenues from Colombia.